ID: ALA1773785

Max Phase: Preclinical

Molecular Formula: C19H19N3O2S

Molecular Weight: 353.45

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(Cc1ccccc1)N1CCC(c2nc(-c3cccs3)no2)CC1

Standard InChI:  InChI=1S/C19H19N3O2S/c23-17(13-14-5-2-1-3-6-14)22-10-8-15(9-11-22)19-20-18(21-24-19)16-7-4-12-25-16/h1-7,12,15H,8-11,13H2

Standard InChI Key:  FNAMKJFTCMWMKP-UHFFFAOYSA-N

Associated Targets(non-human)

ethR HTH-type transcriptional regulator EthR (94 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 353.45Molecular Weight (Monoisotopic): 353.1198AlogP: 3.75#Rotatable Bonds: 4
Polar Surface Area: 59.23Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.54CX LogD: 3.54
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.72Np Likeness Score: -2.16

References

1. Flipo M, Desroses M, Lecat-Guillet N, Dirié B, Carette X, Leroux F, Piveteau C, Demirkaya F, Lens Z, Rucktooa P, Villeret V, Christophe T, Jeon HK, Locht C, Brodin P, Déprez B, Baulard AR, Willand N..  (2011)  Ethionamide boosters: synthesis, biological activity, and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitors.,  54  (8): [PMID:21417236] [10.1021/jm200076a]

Source